TGA
Valerian under scrutiny
The TGA is investigating the safety of Valerian following a small number of reports of liver injury Noting common uses for Valeriana officinalis – such as to help manage nervousness, …
Compounding changes
TGA seeks feedback on proposed changes to compounded medicines guidelines The Therapeutic Goods Administration is seeking submissions from interested parties on its proposed changes to compounded medicine manufacturing practices and …
Vita Gummies makers slammed with $164k fine
The manufacturers allegedly omitted milk products as an allergen on the ingredient warning in advertising two products targeted at children The TGA has issued 13 infringement notices totalling $164,520 to …
Undeclared sildenafil
The TGA has asked people in possession of Maxman XI tablets to bring them to their pharmacy for safe disposal The TGA issued a statement saying that it has tested …
Fines up to $26.6k doled out
Five companies and one Melbourne woman have been fined for alleged unlawful importation of medical and surgical face masks in relation to COVID-19 Two Melbourne-based companies and two Sydney-based companies …
No more ads
TGA warns off advertising for first aid creams containing a cancelled NSAID The Therapeutic Goods Administration (TGA) is reminding advertisers that first aid creams containing bufexamac cannot be advertised to …
‘We would not want the pharmacy profession being set up to fail.’
Stakeholders have welcomed an interim TGA decision to downschedule low-dose cannabidiol to S3 – but the peak pharmacist body warns that evidence and therapeutic purpose are key The TGA has …
Mixed results on scheduling
Migraine treatment and immediate release ibuprofen set to be downscheduled, but no change to status of another high profile medicine The migraine treatment eletriptan is to move to Schedule 3 …
Stock issues strike again
TGA announces more medicine shortages are now impacting Australia The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that there is an ongoing shortage of medicines containing olmesartan …
Court proceedings over alleged unlawful advertising
The TGA has initiated Federal Court proceedings over the advertising of hyperbaric oxygen therapy chambers as a treatment for conditions including COVID-19 and autism The proceedings were initiated in response …
In short supply
TGA warns of a serious shortage of HRT patches, and their planned replacements, as well as some oral contraceptives Australia is facing a shortage of estradiol patches which will last …
Mixed decisions from scheduling committee
Ranitidine set to remain an S3 medicine, while TGA decides to downschedule migraine and acne treatments The Therapeutic Goods Administration (TGA) scheduling delegate has confirmed that the reflux treatment ranitidine …